Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 2
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sharif j[au] (90 results)?
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells.
Raychaudhuri D, Bhattacharya R, Sinha BP, Liu CSC, Ghosh AR, Rahaman O, Bandopadhyay P, Sarif J, D'Rozario R, Paul S, Das A, Sarkar DK, Chattopadhyay S, Ganguly D. Raychaudhuri D, et al. Among authors: sarif j. Front Immunol. 2019 Aug 7;10:1878. doi: 10.3389/fimmu.2019.01878. eCollection 2019. Front Immunol. 2019. PMID: 31440253 Free PMC article.
Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani.
Das N, Roy J, Patra B, Saunders E, Sarkar D, Goon S, Sinha BP, Roy S, Roy S, Sarif J, Bandopadhyay P, Barik S, Mukherjee S, McNamara N, Varghese S, Simpson K, Baell J, McConville M, Ganguly D, Talukdar A. Das N, et al. Among authors: sarif j. Eur J Med Chem. 2024 Apr 5;269:116256. doi: 10.1016/j.ejmech.2024.116256. Epub 2024 Feb 27. Eur J Med Chem. 2024. PMID: 38461679
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
Bandopadhyay P, D'Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR, Roy R, Maiti R, Chaudhuri K, Bagchi S, Maiti A, Perwez MM, Sarkar BS, Roy D, Chakraborty R, Vasudevan JS, Sharma S, Biswas D, Maiti C, Saha B, Bhattacharya P, Pandey R, Chatterjee S, Paul S, Ganguly D. Bandopadhyay P, et al. Among authors: sarif j. J Infect Dis. 2021 Aug 16;224(4):565-574. doi: 10.1093/infdis/jiab010. J Infect Dis. 2021. PMID: 34398242 Free PMC article. Clinical Trial.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Ray Y, Paul SR, Bandopadhyay P, D'Rozario R, Sarif J, Raychaudhuri D, Bhowmik D, Lahiri A, Vasudevan JS, Maurya R, Kanakan A, Sharma S, Kumar M, Singh P, Roy R, Chaudhury K, Maiti R, Bagchi S, Maiti A, Perwez MM, Mondal A, Tewari A, Mandal S, Roy A, Saha M, Biswas D, Maiti C, Bhaduri R, Chakraborty S, Sarkar BS, Haldar A, Saha B, Sengupta S, Pandey R, Chatterjee S, Bhattacharya P, Paul S, Ganguly D. Ray Y, et al. Among authors: sarif j. Nat Commun. 2022 Jan 19;13(1):383. doi: 10.1038/s41467-022-28064-7. Nat Commun. 2022. PMID: 35046397 Free PMC article. Clinical Trial.
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19.
Raychaudhuri D, Bandopadhyay P, D'Rozario R, Sarif J, Ray Y, Paul SR, Singh P, Chaudhuri K, Bhaduri R, Pandey R, Bhattacharya P, Sengupta S, Chatterjee S, Ganguly D. Raychaudhuri D, et al. Among authors: sarif j. Mayo Clin Proc Innov Qual Outcomes. 2022 Dec;6(6):511-524. doi: 10.1016/j.mayocpiqo.2022.09.001. Epub 2022 Sep 14. Mayo Clin Proc Innov Qual Outcomes. 2022. PMID: 36117954 Free PMC article.
11 results